JP2023515927A5 - - Google Patents
Info
- Publication number
- JP2023515927A5 JP2023515927A5 JP2022549759A JP2022549759A JP2023515927A5 JP 2023515927 A5 JP2023515927 A5 JP 2023515927A5 JP 2022549759 A JP2022549759 A JP 2022549759A JP 2022549759 A JP2022549759 A JP 2022549759A JP 2023515927 A5 JP2023515927 A5 JP 2023515927A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062978694P | 2020-02-19 | 2020-02-19 | |
| US62/978,694 | 2020-02-19 | ||
| PCT/US2021/018831 WO2021168290A1 (en) | 2020-02-19 | 2021-02-19 | Multilamellar rna nanoparticles and methods of sensitizing tumors to treatment with immune checkpoint inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515927A JP2023515927A (ja) | 2023-04-17 |
| JPWO2021168290A5 JPWO2021168290A5 (https=) | 2024-02-27 |
| JP2023515927A5 true JP2023515927A5 (https=) | 2024-02-27 |
Family
ID=77392250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549759A Pending JP2023515927A (ja) | 2020-02-19 | 2021-02-19 | 免疫チェックポイント阻害剤による治療に対して腫瘍を感作させる多重膜ｒｎａナノ粒子および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230346700A1 (https=) |
| EP (1) | EP4106730A4 (https=) |
| JP (1) | JP2023515927A (https=) |
| AU (1) | AU2021222036A1 (https=) |
| CA (1) | CA3168509A1 (https=) |
| WO (1) | WO2021168290A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3999034A4 (en) * | 2019-07-19 | 2023-08-23 | University Of Florida Research Foundation, Incorporated | Multilamellar rna nanoparticles |
| WO2023196232A1 (en) * | 2022-04-04 | 2023-10-12 | University Of Florida Research Foundation, Inc. | Method of characterizing tumors |
| WO2025207807A1 (en) * | 2024-03-27 | 2025-10-02 | The University Of Florida Research Foundation, Inc. | Ctc rna-loaded nanoparticles and use thereof for the treatment of cancer |
| WO2025207936A1 (en) * | 2024-03-28 | 2025-10-02 | Mirror Biologics, Inc. | Treatment for colorectal cancer using immune checkpoint inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3364949A4 (en) * | 2015-10-22 | 2019-07-31 | ModernaTX, Inc. | CANCER VACCINES |
| KR102469450B1 (ko) * | 2016-05-18 | 2022-11-22 | 모더나티엑스, 인크. | 인터류킨-12 (il12)를 코딩하는 폴리뉴클레오티드 및 그의 용도 |
| CA3050614A1 (en) * | 2017-03-17 | 2018-09-20 | Curevac Ag | Rna vaccine and immune checkpoint inhibitors for combined anticancer therapy |
| WO2019222400A2 (en) * | 2018-05-15 | 2019-11-21 | Dnalite Therapeutics, Inc. | Mucus-penetrating peptides, delivery vehicles and methods of therapy |
| WO2020037102A1 (en) * | 2018-08-15 | 2020-02-20 | University Of Florida Research Foundation, Inc. | Methods of sensitizing tumors to treatment with immune checkpoint inhibitors |
| EP3999034A4 (en) * | 2019-07-19 | 2023-08-23 | University Of Florida Research Foundation, Incorporated | Multilamellar rna nanoparticles |
-
2021
- 2021-02-19 US US17/800,687 patent/US20230346700A1/en active Pending
- 2021-02-19 WO PCT/US2021/018831 patent/WO2021168290A1/en not_active Ceased
- 2021-02-19 CA CA3168509A patent/CA3168509A1/en active Pending
- 2021-02-19 EP EP21756388.1A patent/EP4106730A4/en active Pending
- 2021-02-19 AU AU2021222036A patent/AU2021222036A1/en active Pending
- 2021-02-19 JP JP2022549759A patent/JP2023515927A/ja active Pending